TOP TIERMARKET NEWSWIRE
News & sentiment

MILESTONE PHARMACEUT (MIST) — News & AI sentiment

MILESTONE PHARMACEUT (MIST) news roundup. 7 stories aggregated over the last 30 days. Average 30-day sentiment is 53.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
7
avg sentiment 53.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

MIST news in the last 24 hours, 7 days, 30 days and 90 days

How much MIST coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMIST storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days753.7/100MIST headlines →
Last 90 days3655.3/100MIST headlines →

Latest stories on MIST

Oct 20
Oct 19
Oct 19
Oct 9
Oct 9
Oct 9
Oct 8
Sep 24
Sep 24
Sep 3
Sep 3
Sep 3
Sep 2
Sep 2
Aug 27
Aug 21
Milestone Pharmaceuticals stock gains on Phase 3 AFib trial
Investing.com Markets67 · bullishproduct/pr
Aug 21
Aug 21
Aug 21
Aug 20
Aug 20
Aug 20
Milestone (MIST) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Aug 19
Aug 18
Aug 17
Open MIST in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →